Professor Laura Bray
is engineering three-dimensional (3D) “micro tissues” for more efficient drug development, and personalised cancer treatment. Cancer research typically uses 2D surfaces like plastic or glass, which don’t capture how tumours interact with their environment in response to a drug. This gap in knowledge contributes to the high failure rate – up to 90 per cent – of drugs in clinical trials. “Micro tissues” of 3D cell structures could provide vital information on tumour response at the preclinical stage, saving time and money if a drug isn’t viable. This approach could also be applied in the clinic: growing a patient’s cells into a miniaturised tumour model to test which therapy is most likely to work for that individual.
Find Prof Bray’s QUT Academic Profile here.
Read and download the Advanced Biomaterials Capability Statement
